10-Q Filing

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC CIK: 1730430 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001104659-18-049660`
Period End Date	20180630
Filing Date	20180806
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	knsa-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 42 Income Statement 40 Cash Flow Statement 41 Stockholders Equity 15

Balance Sheet 42 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$45.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$285.52M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$105.00K	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$263.00K	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$73.67M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.44M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.42M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.10M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$363.87M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$350.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$125.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$210.00K	USD	Point-in-time
Deferred offering costs	`DeferredCosts`	$25.00K	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$238.00K	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$700.00K	USD	Point-in-time
Total assets	`Assets`	$365.13M	USD	Point-in-time
Total assets	`Assets`	$47.49M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.22M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$561.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.58M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.21M	USD	Point-in-time
Accrued milestone	`AccruedMilestoneLiabilitiesCurrent`	$10.00M	USD	Point-in-time
Accrued milestone	`AccruedMilestoneLiabilitiesCurrent`	$10.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$23.14M	USD	Point-in-time
Deferred rent	`AccruedRentNoncurrent`	$186.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$23.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$17.43M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible preferred shares (Series A, B and C), $0.000273235 par value; 0 shares and 22,885,492 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively; aggregate liquidation preference of $0 and $120,000 as of June 30, 2018 and December 31, 2017, respectvely;	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.29M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$469.02M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$7.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-91.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-127.24M	USD	Point-in-time
Total shareholders' equity (deficit)	`StockholdersEquity`	$341.80M	USD	Point-in-time
Total shareholders' equity (deficit)	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Total liabilities, convertible preferred shares and shareholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$365.13M	USD	Point-in-time
Total liabilities, convertible preferred shares and shareholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$47.49M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$17.20M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$9.27M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$29.83M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$12.42M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.04M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.02M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.33M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.12M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$11.39M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$21.53M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$16.44M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$37.87M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-37.87M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-11.39M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-21.53M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-16.44M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.07M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.37M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$226.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$153.00K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-20.46M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.24M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-36.50M	USD	2 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-16.21M	USD	2 Qtrs
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-36.00K	USD	1 Quarter
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-70.00K	USD	2 Qtrs
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-255.00K	USD	2 Qtrs
Benefit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-202.00K	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-11.20M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-20.26M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-16.14M	USD	2 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-36.24M	USD	2 Qtrs
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.97	USD	1 Quarter
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.09	USD	2 Qtrs
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-6.69	USD	1 Quarter
Net loss per share attributable to common shareholders - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-10.47	USD	2 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.54M	shares	2 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.67M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.74M	shares	2 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.79M	shares	1 Quarter

Cash Flow Statement 41 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-16.14M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-36.24M	USD	2 Qtrs
Depreciation expense	`Depreciation`	$12.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$6.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$20.00K	USD	2 Qtrs
Depreciation expense	`Depreciation`	$12.00K	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$228.00K	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$1.62M	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-66.00K	USD	2 Qtrs
Non-cash rent expense	`NonCashRentExpense`	$208.00K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-69.00K	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-463.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.96M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$942.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$898.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-747.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$5.62M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$119.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-15.90M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-32.89M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$37.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$311.00K	USD	2 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$73.68M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-37.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-73.99M	USD	2 Qtrs
Payments of deferred offering costs	`PaymentsOfStockIssuanceCosts`	$2.83M	USD	2 Qtrs
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$17.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$347.21M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$39.87M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$240.33M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$23.94M	USD	2 Qtrs
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$285.99M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$56.08M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.66M	USD	Point-in-time
Cash and cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.01M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$45.66M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$80.01M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$56.08M	USD	Point-in-time
Cash and cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$285.99M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$148.00K	USD	2 Qtrs
Deferred offering costs included in accrued expenses and accounts payable	`DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable`	$856.00K	USD	2 Qtrs

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of the period	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Balance at the end of the period	`TemporaryEquityCarryingAmountAttributableToParent`	$119.77M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$341.80M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$-89.71M	USD	Point-in-time
Conversion of convertible preferred shares into common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$310.59M	USD	2 Qtrs
Issuance of Class A common shares upon completion of initial public offering, net of underwriting discounts and commissions and offering costs	`StockIssuedDuringPeriodValueNewIssues`	$155.51M	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$17.00K	USD	2 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.62M	USD	2 Qtrs
Unrealized gain (loss) on short term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$7.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-16.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-36.24M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-20.26M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.20M	USD	1 Quarter
Balance at the end of the period	`StockholdersEquity`	$341.80M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$-89.71M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.